Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
VG Life Sciences Inc. is a holding company restructuring its business to focus on real estate investment and acquisitions. VG Life Sciences Inc. is a holding company restructuring its business to focus on real estate investment and acquisitions.
VG Life Sciences Granted Combination Cancer Drug Patent U.S. Patent Covers Group of Compounds Combined With Existing Treatments To Fight Drug-Resistant Cancers PR Newswire SANTA BARBARA, Calif...
VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015 PR Newswire SANTA BARBARA, Calif., June 16, 2015 SANTA BARBARA, Calif., June 16, 2015 /PRNewswire/ -- Dear...
VG Life Sciences Granted Key Composition Of Matter Patent U.S. Patent Covers Synthetic Peptide That Displaces Ectopic CLIP in Chronic Inflammatory Conditions, Autoimmune Disease and Infection PR...
SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from...
SANTA BARBARA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q1 2014 Shareholder Update Letter: May 13, 2014 Dear Shareholders, Here at VG Life Sciences, our...
SANTA BARBARA, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune...
SANTA BARBARA, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test...
SANTA BARBARA, Calif., Jan. 3, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTC Pink: VGLS) a biotechnology company. Pursuant to a vote of the holders having a majority of the...
VG Life Sciences, Inc. Update on Phase I Cancer Study PR Newswire SANTA BARBARA, Calif., Dec. 13, 2013 SANTA BARBARA, Calif., Dec. 13, 2013 /PRNewswire/ -- VG Life Sciences, (OTC Pink: VGLS) a...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 6240721 | 9.948E-5 | CS |
| 4 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 7488628 | 9.053E-5 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 7026732 | 8.763E-5 | CS |
| 26 | 5.0E-5 | 100 | 5.0E-5 | 0.0001 | 1.0E-6 | 5592165 | 8.019E-5 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 11095518 | 8.908E-5 | CS |
| 156 | -0.0016 | -94.1176470588 | 0.0017 | 0.0018 | 1.0E-6 | 62527100 | 0.00025322 | CS |
| 260 | -0.0021 | -95.4545454545 | 0.0022 | 0.03 | 1.0E-6 | 44795946 | 0.00078554 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
